«Fibrogen

Below is an extended Fibrogen patents listing. Click here to return to the Fibrogen main Biocorporate entry.

Fibrogen Patents :
US Patent No.	Title
7405274	Connective tissue growth factor antibodies
5925736	Collagen-based methods and formulations for the treatment of arthritis
5928922	.alpha.2 subunit of prolyl-4-hydroxylase, nucleic acid sequences encoding such subunit and methods for producing the same
6020193	Recombinant C-proteinase and processes, methods and uses thereof
6348329	Nucleic acids encoding rat connective tissue growth factor (CTGF) and methods of use
6358741	Connective tissue growth factor (CTGF) and methods of use
6462063	C-proteinase inhibitors
6506936	N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production
6555322	.alpha.2-macroglobulin receptor as a receptor for CTGF
6992172	Recombinant gelatins
7115390	Connective tissue growth factor fragments and methods and uses thereof
7323475	Nitrogen-containing heteroaryl compounds and methods of use thereof
7393928	Recombinant gelatins
5807981	Peptides which are cleaved by C-proteinase

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.